AEST.MED.INT.HLD.SP.ADR/3 Financial Flexibility Index
AEST.MED.INT.HLD.SP.ADR/3 financial flexibility index. AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of €-5.25 Million (operating CF €-12.23 Million minus capex €6.98 Million) represents 0% of total liabilities (€554.12 Million). See 3FMA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
Financial flexibility index of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025. Historical Financial Flexibility Index trend for AEST.MED.INT.HLD.SP.ADR/3 across 5 annual periods. Explore AEST.MED.INT.HLD.SP.ADR/3 (3FMA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
AEST.MED.INT.HLD.SP.ADR/3 Financial Flexibility Index by Year (2021–2025)
AEST.MED.INT.HLD.SP.ADR/3 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for AEST.MED.INT.HLD.SP.ADR/3. For the full cash flow conversion analysis, see 3FMA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | €-5.25 Million | €-12.23 Million | €554.12 Million | ▼ -104.1% |
| 2024 | 0.23x | €110.45 Million | €79.67 Million | €476.88 Million | ▼ -5.9% |
| 2023 | 0.25x | €129.75 Million | €74.29 Million | €527.03 Million | ▲ +325.3% |
| 2022 | -0.11x | €-73.45 Million | €-75.13 Million | €672.25 Million | ▼ -198.7% |
| 2021 | 0.11x | €84.53 Million | €51.09 Million | €763.36 Million | — |